Calcitonin provides complete protection against cancellous bone loss in the femoral neck of ovariectomized rats

Calcified Tissue International

Volumn 60, Issue 5, 1997, Pages 457-461

  Shen, Y ^a   Li, M ^a   Wronski, T J ^a  

^a University of Florida College of Veterinary Medicine   (United States)

Author keywords

Calcitonin; Cancellous bone; Femoral neck; Histomorphometry; Ovariectomy

Indexed keywords

SALCATONIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE ATROPHY; CANCELLOUS BONE; CONTROLLED STUDY; FEMALE; FEMUR NECK; NONHUMAN; OSSIFICATION; OSTEOPENIA; OVARIECTOMY; PRIORITY JOURNAL; PROPHYLAXIS; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; TIBIA;

ANALYSIS OF VARIANCE; ANIMALS; BONE DEVELOPMENT; BONE DISEASES, METABOLIC; BONE RESORPTION; CALCITONIN; FEMALE; FEMUR; OSTEOBLASTS; OSTEOCLASTS; OVARIECTOMY; RATS; RATS, SPRAGUE-DAWLEY; REFERENCE VALUES; TIME FACTORS;

EID: 0030972445     PISSN: 0171967X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002239900262     Document Type: Article

References (30)

1. Melton LJ III (1993) Hip fractures: a worldwide problem today and tomorrow. Bone 14:S1-S8
2. Hofeldt F (1987) Proximal femoral fractures. Clin Orthop 218: 12-18
3. Hedlund R, Lindgren U, Ahlbom A (1987) Age- and sex-specific incidence of femoral neck and trochanteric fractures. Clin Orthop 222:132-139
4. Kanis JA, Johnell O, Gullberg B, Allanda E, Dilsen G, Gennari C, Vaz AAL, Lyritis GP, Mazzuoli G, Miravet L, Passeri M, Cano RP, Rapado A, Ribot C (1992) Evidence for efficacy of drugs affecting bone metabolism in preventing hip fracture. Br Med J 305:1124-1128
5. Johnell O, Stenbeck M, Rosen M, Gullberg B, Kanis JA (1993) Therapeutic strategies in the prevention of hip fracture with drugs affecting bone metabolism. Bone 14:S85-S87
6. Kalu DN (1991) The ovariectomized rat model of postmenopausal bone loss. Bone Miner 15:175-192
7. Shen Y, Li M, Wronski TJ (1996) Skeletal effects of calcitonin treatment and withdrawal in ovariectomized rats. Calcif Tissue Int 58:263-267
8. Bonucci E, Ballanti P, Ramires PA, Richardson JL, Benedetti LM (1995) Prevention of ovariectomy osteopenia in rats after vaginal administration of hyaff 11 microspheres containing salmon calcitonin. Calcif Tissue Int 56:274-279
9. Li M, Shen Y, Burton KW, DeLuca PP, Mehta RC, Baumann BD, Wronski TJ (1996) A comparison of the skeletal effects of intermittent and continuous administration of calcitonin in ovariectomized rats. Bone 18:375-380
10. Wronski TJ, Schenck PA, Cintrón M, Walsh CC (1987) Effect of body weight on osteopenia in ovariectomized rats. Calcif Tissue Int 40:155-159
11. Baron R, Vignery A, Neff L, Silvergate A, Santa Maria A (1983) Processing of undecalcified bone specimens for bone histomorphometry. In: Recker RR (ed) Bone histomorphometry: techniques and interpretation. CRC Press, Boca Raton, FL, pp 13-35
12. Li M, Wronski TJ (1995) Response of femoral neck to estrogen depletion and parathyroid hormone in aged rats. Bone 16:551-557
13. Wronski TJ, Dann LM, Qi H, Yen C-F (1993) Skeletal effects of withdrawal of estrogen and diphosphonate treatment in ovariectomized rats. Calcif Tissue Int 53:210-216
14. Parfitt AM, Mathews CHE, Villaneuva AR;, Kleerekoper M, Frame B, Rao DS (1983) Relationships between surface, volume, and thickness of iliac trabecular bone in aging and in osteoporosis. J Clin Invest 72:1396-1409
15. Frost HM (1983) Bone histomorphometry: analysis of trabecular bone dynamics. In: Recker RR (ed) Bone histomorphometry: techniques and interpretation. CRC Press, Boca Raton, FL, pp 109-132
16. Frost HM (1977) Histomorphometry of trabecular bone: theoretical correction of appositional rate measurement. In: Meunier PJ (ed) Bone histomorphometry. Societe de la Nouvelle Imprimerie Fournie, Toulouse. France, pp 361-370
17. Neter J, Wasserman W, Whitmore GA (1982) Applied statistics. Allyn and Bacon, Boston, MA, pp 544-572
18. McSheehy PMJ, Farina C, Airaghi R, Allievi E, Banfi S, Bertolini D, Ferni G, Frattola D, Oneta S, Pinza M, Sorini C, Valente M, Volontieri A (1995) Pharmacologie evaluation of the calcitonin analogue SB 205614 in models of osteoclastic bone resorption in vitro and in vivo: comparison with salmon calcitonin and elcatonin. Bone 16:435-444
19. Wronski TJ, Dann LM, Scott KS, Crooke LR (1989) Endocrine and pharmacological suppressors of bone turnover protect against osteopenia in ovariectomized rats. Endocrinology 125:810-816
20. Wronski TJ, Yen C-F, Scott KS (1991) Estrogen and diphosphonate treatment provide long-term protection against osteopenia in ovariectomized rats. J Bone Miner Res 6:387-394
21. MacIntyre I, Whitehead MI, Banks LM, Stevenson JC, Wimalawansa SJ, Healy MJR (1988) Calcitonin for prevention of postmenopausal bone loss. Lancet 2:900-901
22. Reginster JY, Albert A, Lecart MP, Lamberlin P, Denis D, Deroisy R, Fontaine MA, Franchimont P (1987) One-year controlled randomised trial of prevention of early postmenopausal bone loss by intranasal calcitonin. Lancet 2:1481-1483
23. Gennari C, Agnusdei D, Montagnani M, Gonnelli S, Civitelli R (1992) An effective regimen of intranasal salmon calcitonin in early postmenopausal bone loss. Calcif Tissue Int 50:381-383
24. Mazzuoli GF, Tabolli S, Bigi F, Valtorta C, Minisola S, Diacinti D, Scarnecchia L, Bianchi C, Piolini M, Dell'Acqua S (1990) Effects of salmon calcitonin on the bone loss induced by ovariectomy. Calcif Tissue Int 47:209-214
25. Civitelli R, Gonnelli S, Zacchei F, Bigazzi S, Vattimo A, Avioli LV, Gennari C (1988) Bone turnover in postmenopausal osteoporosis: effect of calcitonin treatment. J Clin Invest 82:1268-1274
26. Overgaard K, Hansen MA, Nielsen V-AH, Riis BJ, Christiansen C (1990) Discontinuous calcitonin treatment of established osteoporosis - effects of withdrawal of treatment. Am J Med 89:1-6
27. Kollerup G, Hermann AP, Brixen K, Lindblad BE, Mosekilde L, Sørensen OH (1994) Effects of salmon calcitonin suppositories on bone mass and turnover in established osteoporosis. Calcif Tissue Int 54:12-15
28. Adami S, Passeri M, Ortolani S, Broggini M, Carratelli L, Caruso I, Gandolini G, Gnessi L, Laurenzi M, Lombards A, Norbiato G, Pryor-Tillotson S, Reda C, Romanini L, Subrizi D, Wei L, Yates AJ (1995) Effects of oral alendronate and intranasal salmon calcitonin on bone mass and biochemical markers of bone turnover in postmenopausal women with osteoporosis. Bone 17:383-390
29. Arnala I, Saastamoinen J, Alhava EM (1996) Salmon calcitonin in the prevention of bone loss at perimenopause. Bone 4:629-632
30. Thamsborg G, Jensen JEB, Kollerup G, Hauge EM, Melsen F, Sørensen OH (1996) Effect of nasal salmon calcitonin on bone remodeling and bone mass in postmenopausal osteoporosis. Bone 18:207-212